Us Congress 2025-2026 Regular Session

Us Congress House Bill HR172 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 IV
22 119THCONGRESS
33 1
44 STSESSION H. RES. 172
55 Raising awareness for the sarcoma cancer chordoma.
66 IN THE HOUSE OF REPRESENTATIVES
77 FEBRUARY27, 2025
88 Mr. J
99 OHNSONof Georgia (for himself, Mrs. MCBATH, Ms. WILSONof Florida,
1010 Ms. V
1111 ELA´ZQUEZ, and Ms. NORTON) submitted the following resolution;
1212 which was referred to the Committee on Energy and Commerce
1313 RESOLUTION
1414 Raising awareness for the sarcoma cancer chordoma.
1515 Whereas chordoma is a slow growing, yet aggressive bone
1616 cancer of the skull and spine;
1717 Whereas it strikes people of all ages and affects more than
1818 25,000 individuals worldwide;
1919 Whereas, each year, thousands of people are diagnosed with
2020 chordoma including about 300 people annually in the
2121 United States;
2222 Whereas chordomas are among the most complicated tumors
2323 to treat due to involvement of critical structures such as
2424 the brain stem, spinal cord, and important nerves and ar-
2525 teries;
2626 Whereas surgery or radiation performed by a skilled treat-
2727 ment team can be curative for some patients, but even
2828 VerDate Sep 11 2014 23:10 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR172.IH HR172
2929 ssavage on LAPJG3WLY3PROD with BILLS 2
3030 •HRES 172 IH
3131 with the best care possible, the recurrence rate remains
3232 high; and
3333 Whereas no drugs are known to cure or effectively control the
3434 disease, meaning that patients whose disease progresses
3535 after exhausting surgical and radiation options have little
3636 hope for a full recovery: Now, therefore, be it
3737 Resolved, That it is the sense of the House of Rep-1
3838 resentatives that chordoma patients and families need in-2
3939 creased funding and support for— 3
4040 (1) accurate and early diagnosis; 4
4141 (2) the development of new treatments, 5
4242 diagnostics, and cures; 6
4343 (3) fewer hurdles between research and new 7
4444 treatments; and 8
4545 (4) patient-centric approaches to drug discovery 9
4646 and development. 10
4747 Æ
4848 VerDate Sep 11 2014 23:10 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\HR172.IH HR172
4949 ssavage on LAPJG3WLY3PROD with BILLS